1. Academic Validation
  2. Tetrahydroquinolinone derivatives exert antiproliferative effect on lung cancer cells through apoptosis induction

Tetrahydroquinolinone derivatives exert antiproliferative effect on lung cancer cells through apoptosis induction

  • Sci Rep. 2022 Nov 9;12(1):19076. doi: 10.1038/s41598-022-23640-9.
Małgorzata Ryczkowska # 1 Natalia Maciejewska # 2 Mateusz Olszewski 2 Milena Witkowska 1 Sławomir Makowiec 3
Affiliations

Affiliations

  • 1 Department of Organic Chemistry, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233, Gdansk, Poland.
  • 2 Department of Pharmaceutical Technology and Biochemistry, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233, Gdansk, Poland.
  • 3 Department of Organic Chemistry, Faculty of Chemistry, Gdansk University of Technology, Narutowicza 11/12, 80-233, Gdansk, Poland. mak@pg.edu.pl.
  • # Contributed equally.
Abstract

The Anticancer properties of quinolones is a topic of interest among researchers in the scientific world. Because these compounds do not cause side effects, unlike the commonly used cytostatics, they are considered a promising source of new Anticancer drugs. In this work, we designed a brief synthetic pathway and obtained a series of novel 8-phenyltetrahydroquinolinone derivatives functionalized with benzyl-type moieties at position 3. The compounds were synthesized via classical reactions such as nucleophilic substitution, solvent lysis, and condensation. Biological evaluation revealed that 3-(1-naphthylmethyl)-4-phenyl-5,6,7,8-tetrahydro-1H-quinolin-2-one (4a) exhibited potent cytotoxicity toward colon (HTC-116) and lung (A549) Cancer cell lines. Analysis of the mechanism of action of compounds showed that compound 4a induced cell cycle arrest at the G2/M phase, leading to apoptotic cell death via intrinsic and extrinsic pathways. Taken together, the findings of the study suggest that tetrahydroquinolinone derivatives bearing a carbonyl group at position 2 could be potential lead compounds to develop Anticancer agents for the treatment of lung cancers.

Figures
Products